Julie Mayo Lamberte
Centers for Disease Control and Prevention(US)National Center for Immunization and Respiratory Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, COVID-19 epidemiological studies, Viral gastroenteritis research and epidemiology, Infection Control and Ventilation
Most-Cited Works
- → Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021(2021)790 cited
- → Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines(2021)520 cited
- → Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022(2022)182 cited
- → Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines(2021)56 cited
- → Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021(2021)46 cited
- → COVID-19 Infection, Reinfection, and Vaccine Effectiveness in Arizona Frontline and Essential Workers: Protocol for a Longitudinal Cohort Study(2021)44 cited
- → Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study(2021)28 cited
- → COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers(2021)27 cited
- → Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies(2023)17 cited
- → Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers(2023)16 cited